SEC Form 4 · accession 0001654954-17-004944
NAVIDEA BIOPHARMACEUTICALS, INC. · NAVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jed Latkin
Officer — COO and CFO
Period of report
May 17, 2017
Accepted (ET)
May 19, 2017 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000810509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.001 par value | May 17, 2017 | A | 13,300 | $0.467 | A | 13,300 | D | |
| Common Stock, $.001 par value | May 18, 2017 | A | 3,900 | $0.4496 | A | 17,200 | D |
Table II — derivative securities
No Table II lines on this filing.